Page 1 of 103 Diabetes RNA-sequencing identifies dysregulation of the human pancreatic islet transcriptome by the saturated fatty acid palmitate Miriam Cnop1,2, Baroj Abdulkarim1, Guy Bottu1, Daniel A Cunha1, Mariana Igoillo-Esteve1, Matilde Masini3, Jean-Valery Turatsinze1, Thasso Griebel4, Olatz Villate1, Izortze Santin1, Marco Bugliani3, Laurence Ladriere1, Lorella Marselli3, Mark I McCarthy5,6,7, Piero Marchetti3, Michael Sammeth4,8, Décio L Eizirik1 1Laboratory of Experimental Medicine, Université Libre de Bruxelles (ULB) and 2Division of Endocrinology, Erasmus Hospital, 1070 Brussels, Belgium; 3Department of Endocrinology and Metabolism, University of Pisa, Pisa, Italy; 4Functional Bioinformatics (FBI), Centre Nacional d'Anàlisi Genòmica (CNAG), 08028 Barcelona, Spain; 5Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM) and 6Oxford NIHR Biomedical Research Centre, Churchill Hospital, Oxford, OX3 7LJ; 7Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, OX3 7BN, UK; 8Laboratório Nacional de Computação Cientifica (LNCC), 25651-076 Petropolis, Rio de Janeiro, Brazil. Running title: RNA-seq of palmitate-treated human islets Corresponding author: Miriam Cnop Laboratory of Experimental Medicine, Université Libre de Bruxelles (ULB) Route de Lennik 808 CP-618, 1070 Brussels, Belgium Tel: 32 2 555 6305; Fax: 32 2 555 6239;
[email protected] Word count: 5,331 Number of tables and figures: 8 1 Diabetes Publish Ahead of Print, published online December 30, 2013 Diabetes Page 2 of 103 Abstract Pancreatic β-cell dysfunction and death are central in the pathogenesis of type 2 diabetes. Saturated fatty acids cause β-cell failure and contribute to diabetes development in genetically predisposed individuals. Here we used RNA-sequencing to map transcripts expressed in five palmitate-treated human islet preparations, observing 1,325 modified genes.